Bio-Link, Verdot Partner on Bioprocessing Technologies

Bio-Link, a bioprocessing company, and Verdot, a downstream bioprocessing firm, signed a strategic partnership agreement under which Bio-Link will become the major distributor for Verdot’s chromatography columns in the Chinese market.

The partnership brings together Bio-Link’s knowledge of the bioprocessing market in China and Verdot’s chromatography technologies, including their expertise in large-scale columns.

Charles Ruban, the President, and CEO of Verdot, said, “Bio-Link is a rising force within the Chinese life science industry, and has a strong reputation within the field of bioprocessing. Bio-Link’s commitment to excellence and their strong market presence make them the perfect partner for our innovative bioprocessing technologies. Together, we aim to empower biopharmaceutical companies in China with advanced solutions that drive efficiency and quality, particularly for large-scale and commercial production.”

Chen Zhi, chairman and president of Bio-Link, said, “By integrating Verdot’s chromatography columns into our product portfolio, we aim to enhance the efficiency and performance of bioprocessing workflows. Verdot consistently drives the development of new biotherapeutic approaches with high-quality products, increasing the accessibility of biopharmaceuticals. We hope that this collaboration can promote industry progress and benefit more patients.”